Research Progress of CD80 in Immunotherapy
Author Information
Author(s): Li Lanying, Yang Lei, Jiang DePeng
Primary Institution: The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
Hypothesis
CD80 plays a crucial role in T cell activation and can be targeted for immunotherapy in tumors and autoimmune diseases.
Conclusion
CD80 is a promising target for developing immunotherapy drugs due to its significant role in T cell activation and regulation of immune responses.
Supporting Evidence
- CD80 is expressed on various immune cells and tumor cells, playing a key role in T cell activation.
- Targeting CD80 can enhance anti-tumor immunity and may improve outcomes in cancer treatment.
- CD80's interaction with PD-L1 and CTLA-4 provides insights into its dual role in immune activation and suppression.
Takeaway
CD80 helps our immune system fight cancer and autoimmune diseases, and scientists are studying how to use it to make better medicines.
Methodology
This review summarizes the role of CD80 in the immune system and its potential applications in immunotherapy.
Limitations
The review does not provide specific experimental data or clinical trial results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website